Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
According to the U.S. Sucralfate Market Report, by Formulation (Tablet and Liquid Suspension), by Indication (Gastric Ulcers, Duodenal Ulcers, Gastro-Esophageal Reflux Disease (GERD), and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by State (Illinois, Texas, New York, California, and Others), published by Coherent Market Insights, the U.S. sucralfate market was valued at US$ 296.2 million in 2017 and is projected to exhibit a CAGR of 3.1% over the forecast period (2018–2026).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-sample/2975
Increasing prevalence of peptic ulcers and duodenal is expected to boost growth of the U.S. sucralfate market over the forecast period. For instance, according to the American Association for the Study of Liver Diseases report of 2018, in the U.S., peptic ulcer disease (PUD) affects around 4.5 million people, annually in the U.S.
Increasing prescription of sucralfate for different indications is expected to propel growth of the U.S. sucralfate market over the forecast period. For instance, according to the Medical Expenditure Panel Survey (MEPS) report of 2019, 2 million prescriptions of sucralfate were sold in the U.S. in 2016 for different indications such as stomach ulcers, gastro-esophageal reflux disease, and others. Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the report on ‘Aging in United States’ in 2016, the number of people in the U.S. aged 65 years and above older is projected to double from 46 million in 2016 to over 98 million by 2060.
Among formulation, the tablet segment is expected to account for the largest market share in the U.S. sucralfate market in 2018, owing to recommendation of sucralfate tablets in various types of gastric ulcers. For instance, sucralfate tablets are indicated for the treatment of duodenal and non-malignant gastric ulcer. They are also indicated for prophylaxis of duodenal ulcer recurrence.
Among distribution channel, the retail pharmacies segment is expected to account for the largest market share the U.S. sucralfate market in 2018, owing to increasing number of retail or independent pharmacies. For instance, according to PLOS Journal, August 2017, the number of independent pharmacies in the U.S. exhibited 3.8% growth from 22,737 (2007) to 23,596 (2015).
Key players in the market and government authorities are focused on updating the product information and creating awareness, in order to avoid any serious side effect of sucralfate. For instance, in August 2017, Teva Pharmaceutical Industries, Ltd. and Mylan, Inc., product Carafate received the U.S. Food and Drug Administration approval for change in the labelling information. The warning and precaution included labeling the risk such as pulmonary and cerebral emboli, owing to the inappropriate administration of Carafate intravenously.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2975
- The U.S. sucralfate market is expected to exhibit a CAGR of 3.1% over the forecast period
- Increasing prevalence of peptic ulcers and duodenal is expected to boost growth of the U.S. sucralfate market over the forecast period
- Key players operating in the U.S. sucralfate market include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and Pharmaceutical Associates Inc.
Other Related Reports:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027